Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Wednesday, January 22, 2025Shuttle Pharmaceuticals Holdings Inc a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy RT announced today that it has achieved enrollment
Aliri Launches qPCR to Complement Existing Lineup of Multi-omics Platforms
Wednesday, January 22, 2025Aliri Bioanalysis a leading provider of advanced bioanalytical and spatial biology solutions for drug developers is pleased to announce the addition of quantitative polymerase chain reaction analysis qPCR to our extensive list of analytical services
Segra International and GreenBe Pharma Forge a Partnership to Streamline Access to Elite Cannabis Genetics Across Europe
Tuesday, January 21, 2025Segra Internationala globally recognized leader in cannabis agtech and genetics is pleased to announce a strategic partnership with GreenBe Pharma a premier European medicinal cannabis producer
European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer
Tuesday, January 21, 2025GSK plctoday announced the European Commission has approved Jemperli dostarlimab in combination with chemotherapy carboplatin and paclitaxel for firstline treatment of adult patients with primary advanced or recurrent endometrial cancer who are candi...
Boehringer provides update on iclepertin Phase III program in schizophrenia
Friday, January 17, 2025Boehringer Ingelheim today announced topline results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia showing primary and key secondary endpoints were not met Overall no statistically significant effects...
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
Friday, January 17, 2025Nusano a physics company transforming the production of radioisotopes and Atley Solutions a global leader in commercial products and services for astatinerelated pharmaceutical development and manufacturing today announced a nonexclusive memorandum o...
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
Thursday, January 16, 2025Lyndra Therapeutics a clinicalstage biopharmaceutical company pioneering longacting oral therapies today announced a strategic collaboration with Thermo Fisher Scientific Inc the world leader in serving science
Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial Initiation in 2025
Thursday, January 16, 2025Sinaptica Therapeutics Inc a clinicalstage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimers and other primary neurodegenerative diseases today announced that codevelopment of the SinaptiS...
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
Wednesday, January 15, 2025BioMed X an independent biomedical research institute based in Heidelberg Germany announced today the launch of a new collaboration with Daiichi Sankyo Co Ltd a global pharmaceutical company headquartered in Japan This collaboration marks the start o...
Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System
Wednesday, January 15, 2025Vetter a globally operating Contract Development and Manufacturing Organization CDMO has announced the development and upcoming launch of the new version of its proprietary VOVS syringe closure system The new closure VOVS next will further advance a...
